Aging and the Kidney
Possible Mechanisms, Consequences, and Management Strategies
- 1st Edition - July 1, 2026
- Latest edition
- Editors: Stephen Fadem, Ahmed Arslan Yousuf Awan, Emaad Abdel-Rahman
- Language: English
Aging and the Kidney: Possible Mechanisms, Consequences, and Management Strategies explores the connection between kidney health and overall well-being with increasing age and lo… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
The second part examines the functional decline in elderly patients and includes subparts on impaired quality of life, sleep quality, fall risk, frailty, depression, and sarcopenia. It also considers unique features of hypertension, diabetes, glomerulonephritis, and peripheral vascular disease. The final part focuses on diagnostic, management, and prevention strategies. The common myths about chronic kidney disease in the elderly are addressed, with particular attention to how a solitary kidney in living donors ages over time. Kidney function and its relationship to neurologic complications, cancers, and cardiovascular disease are explained, along with current treatment approaches, medications, and future directions in the care of elderly patients. This comprehensive work serves as a valuable resource for understanding how aging affects systemic health and offers potential pathways to enhance lifespan and well-being in elderly patients.
Key features
Key features
- Covers histological, structural, physiological, and functional changes leading to a decline in kidney function with aging
- Summarizes the most up-to-date research on the kidney’s impact on health and lifespan
- Addresses common myths regarding kidney disease in the elderly
- Provides guidance on diagnostic, management, and prevention strategies in kidney health and disease for the aging patient
Readership
Readership
Table of contents
Table of contents
1. Structure and physiological changes in the aging kidney
2. Models of aging kidney
3. Molecular mechanisms of aging in the kidney
4. The podocyte
5. Epigenetics and the kidney
6. The influence of acute kidney injury on aging
7. Nutritional considerations and aging
8. Proteomics in the kidney
PART 2 – Clinical Consequences
9. Functional impairment in elderly CKD patients
10. Unique characteristics of kidney diseases in the elderly
PART 3 – Management and Prevention
11. How to make a diagnosis of CKD in an elderly individual, since a decline in GFR is expected with normal healthy aging
12. Myths about CKD in the elderly
13. The living donor and aging
14. CNS limitations in the elderly kidney patient
15. Cancer and the kidney in an elderly individual
16. CKD and cardiovascular diseases (CVD) in an elderly individual
17. Benefits of RAAS blockage
18. Newer drugs and CKD
19. Drugs to avoid with geriatric kidney disease
20. Conservative management of ESRD
Product details
Product details
- Edition: 1
- Latest edition
- Published: July 1, 2026
- Language: English
About the editors
About the editors
SF
Stephen Fadem
Stephen Z Fadem has been in clinical practice since 1978 and is currently a Clinical Professor of Medicine at Baylor College of Medicine. During his career, he has been involved in both teaching and clinical research. Dr. Fadem’s special interests revolve around how the morbidities associated with advancing kidney disease lead to sarcopenia and frailty. He is currently in the process of planning a large fall prevention research project for dialysis patients. He has participated in 44 clinical trials and currently has 93 publications and book chapters, as well as 38 patient education articles. Dr. Fadem is the recipient of several national awards. He has been recognized as a Top Doctor by Castle-Connolly for several years, has won the Medal of Excellence from AAKP, and the Presidents Lifetime Achievement Award.
AA
Ahmed Arslan Yousuf Awan
Dr. Ahmed Arslan Yousuf Awan is a practicing nephrologist and Assistant Professor, Department of Medicine, Nephrology and Abdominal Transplantation at the Baylor College of Medicine. Dr. Awan is founder and director of Hepatorenal services and site director for Nephrology fellowships at Baylor St. Luke’s Medical Center (BSLMC) and is the elected faculty senator for BSLMC. He is winner of Faculty of the Year award, Leadership award, Excellence in Patient Care award and has received the Houstonia top doctors award for 3 consecutive years. He is the principal investigator for an ongoing study regarding racial disparities in living kidney donation and a member of the KDIGO focused group that recently published updated guidelines regarding management of hepatitis C and CKD. He is on the faculty at Baylor College of Medicine as well as a lead in innovative national and international courses like Nephrology Business Leaders University (NBLU) and the GlomCon Fellowship.
EA
Emaad Abdel-Rahman
Emaad M Abdel-Rahman, MD, PhD, has been a nephrologist for over three decades specializing in caring for elderly patients with kidney disease, dialysis patients, and patients with acute and chronic kidney diseases. He is director of the UVA Kidney Center Clinic and main hemodialysis unit and leads one of the few home hemodialysis units in the country. Abdel-Rahman has been actively involved in clinical research throughout his career, including both investigator-initiated and industry-related trials. Dr Abdel-Rahman is a recipient of the UVA School of Medicine Dean’s Award for Clinical Excellence and the Department of Medicine Mentoring Excellence award. He has served on the Advisory Geriatric Nephrology Committee and as a member of the steering committee of the Kidney Health Initiative at the American Society of Nephrology. He now serves as interim director of the Nephrology Clinical Research Center within the UVA Division of Nephrology.